The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Orthostatic Hypotension-Global Market Insights and Sales Trends 2025
Synopsis
Orthostatic hypotension, also known as postural hypotension, is a state of dizziness that is caused due to low blood pressure. This is commonly happen when a person stands up from a long sitting and feel dizziness. Orthostatic hypotension can be caused due to heart problems, dehydration, endocrine problems and nervous system disorders.
The global Orthostatic Hypotension market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Orthostatic Hypotension in various end use industries. The expanding demands from the Hospitals, Clinics and Ambulatory Surgical Centers,, are propelling Orthostatic Hypotension market. ECG, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Blood Tests segment is estimated at % CAGR for the next seven-year period.
The orthostatic hypotension disorder is mostly common in the elderly, teenagers and postpartum mothers. The key drivers that can boost the orthostatic hypotension market are increasing in the aging population with increase in the prevalence of diabetes and heart disorders along with availability of increasing number of treatments options. Increasing adoption and integration of technologies in healthcare premises along with emergence of new entrants in the existing market is expected to further propel the demand for treatment of orthostatic hypotension worldwide.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Orthostatic Hypotension, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Orthostatic Hypotension market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Orthostatic Hypotension market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Orthostatic Hypotension sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Orthostatic Hypotension covered in this report include Mylan, Roche, Upsher-Smith Laboratories, Chelsea Therapeutics, Amgen and Apotex, etc.
The global Orthostatic Hypotension market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Mylan
Roche
Upsher-Smith Laboratories
Chelsea Therapeutics
Amgen
Apotex
Global Orthostatic Hypotension market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Orthostatic Hypotension market, Segment by Type:
ECG
Blood Tests
Stress Test
Echocardiogram
Global Orthostatic Hypotension market, by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Orthostatic Hypotension companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Orthostatic hypotension, also known as postural hypotension, is a state of dizziness that is caused due to low blood pressure. This is commonly happen when a person stands up from a long sitting and feel dizziness. Orthostatic hypotension can be caused due to heart problems, dehydration, endocrine problems and nervous system disorders.
The global Orthostatic Hypotension market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Orthostatic Hypotension in various end use industries. The expanding demands from the Hospitals, Clinics and Ambulatory Surgical Centers,, are propelling Orthostatic Hypotension market. ECG, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Blood Tests segment is estimated at % CAGR for the next seven-year period.
The orthostatic hypotension disorder is mostly common in the elderly, teenagers and postpartum mothers. The key drivers that can boost the orthostatic hypotension market are increasing in the aging population with increase in the prevalence of diabetes and heart disorders along with availability of increasing number of treatments options. Increasing adoption and integration of technologies in healthcare premises along with emergence of new entrants in the existing market is expected to further propel the demand for treatment of orthostatic hypotension worldwide.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Orthostatic Hypotension, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Orthostatic Hypotension market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Orthostatic Hypotension market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Orthostatic Hypotension sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Orthostatic Hypotension covered in this report include Mylan, Roche, Upsher-Smith Laboratories, Chelsea Therapeutics, Amgen and Apotex, etc.
The global Orthostatic Hypotension market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Mylan
Roche
Upsher-Smith Laboratories
Chelsea Therapeutics
Amgen
Apotex
Global Orthostatic Hypotension market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Orthostatic Hypotension market, Segment by Type:
ECG
Blood Tests
Stress Test
Echocardiogram
Global Orthostatic Hypotension market, by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Orthostatic Hypotension companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Orthostatic Hypotension
1.1 Orthostatic Hypotension Market Overview
1.1.1 Orthostatic Hypotension Product Scope
1.1.2 Orthostatic Hypotension Market Status and Outlook
1.2 Global Orthostatic Hypotension Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Orthostatic Hypotension Market Size by Region (2018-2029)
1.4 Global Orthostatic Hypotension Historic Market Size by Region (2018-2023)
1.5 Global Orthostatic Hypotension Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Orthostatic Hypotension Market Size (2018-2029)
1.6.1 North America Orthostatic Hypotension Market Size (2018-2029)
1.6.2 Europe Orthostatic Hypotension Market Size (2018-2029)
1.6.3 Asia-Pacific Orthostatic Hypotension Market Size (2018-2029)
1.6.4 Latin America Orthostatic Hypotension Market Size (2018-2029)
1.6.5 Middle East & Africa Orthostatic Hypotension Market Size (2018-2029)
2 Orthostatic Hypotension Market by Type
2.1 Introduction
2.1.1 ECG
2.1.2 Blood Tests
2.1.3 Stress Test
2.1.4 Echocardiogram
2.2 Global Orthostatic Hypotension Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Orthostatic Hypotension Historic Market Size by Type (2018-2023)
2.2.2 Global Orthostatic Hypotension Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Orthostatic Hypotension Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Orthostatic Hypotension Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Orthostatic Hypotension Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Orthostatic Hypotension Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Orthostatic Hypotension Revenue Breakdown by Type (2018-2029)
3 Orthostatic Hypotension Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Ambulatory Surgical Centers
3.2 Global Orthostatic Hypotension Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Orthostatic Hypotension Historic Market Size by Application (2018-2023)
3.2.2 Global Orthostatic Hypotension Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Orthostatic Hypotension Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Orthostatic Hypotension Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Orthostatic Hypotension Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Orthostatic Hypotension Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Orthostatic Hypotension Revenue Breakdown by Application (2018-2029)
4 Orthostatic Hypotension Competition Analysis by Players
4.1 Global Orthostatic Hypotension Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Orthostatic Hypotension as of 2022)
4.3 Date of Key Players Enter into Orthostatic Hypotension Market
4.4 Global Top Players Orthostatic Hypotension Headquarters and Area Served
4.5 Key Players Orthostatic Hypotension Product Solution and Service
4.6 Competitive Status
4.6.1 Orthostatic Hypotension Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Mylan
5.1.1 Mylan Profile
5.1.2 Mylan Main Business
5.1.3 Mylan Orthostatic Hypotension Products, Services and Solutions
5.1.4 Mylan Orthostatic Hypotension Revenue (US$ Million) & (2018-2023)
5.1.5 Mylan Recent Developments
5.2 Roche
5.2.1 Roche Profile
5.2.2 Roche Main Business
5.2.3 Roche Orthostatic Hypotension Products, Services and Solutions
5.2.4 Roche Orthostatic Hypotension Revenue (US$ Million) & (2018-2023)
5.2.5 Roche Recent Developments
5.3 Upsher-Smith Laboratories
5.3.1 Upsher-Smith Laboratories Profile
5.3.2 Upsher-Smith Laboratories Main Business
5.3.3 Upsher-Smith Laboratories Orthostatic Hypotension Products, Services and Solutions
5.3.4 Upsher-Smith Laboratories Orthostatic Hypotension Revenue (US$ Million) & (2018-2023)
5.3.5 Chelsea Therapeutics Recent Developments
5.4 Chelsea Therapeutics
5.4.1 Chelsea Therapeutics Profile
5.4.2 Chelsea Therapeutics Main Business
5.4.3 Chelsea Therapeutics Orthostatic Hypotension Products, Services and Solutions
5.4.4 Chelsea Therapeutics Orthostatic Hypotension Revenue (US$ Million) & (2018-2023)
5.4.5 Chelsea Therapeutics Recent Developments
5.5 Amgen
5.5.1 Amgen Profile
5.5.2 Amgen Main Business
5.5.3 Amgen Orthostatic Hypotension Products, Services and Solutions
5.5.4 Amgen Orthostatic Hypotension Revenue (US$ Million) & (2018-2023)
5.5.5 Amgen Recent Developments
5.6 Apotex
5.6.1 Apotex Profile
5.6.2 Apotex Main Business
5.6.3 Apotex Orthostatic Hypotension Products, Services and Solutions
5.6.4 Apotex Orthostatic Hypotension Revenue (US$ Million) & (2018-2023)
5.6.5 Apotex Recent Developments
6 North America
6.1 North America Orthostatic Hypotension Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Orthostatic Hypotension Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Orthostatic Hypotension Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Orthostatic Hypotension Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Orthostatic Hypotension Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Orthostatic Hypotension Market Dynamics
11.1 Orthostatic Hypotension Industry Trends
11.2 Orthostatic Hypotension Market Drivers
11.3 Orthostatic Hypotension Market Challenges
11.4 Orthostatic Hypotension Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
